Drug cocktail slashes melanoma recurrence risk in High-Risk patients
NCT ID NCT01682083
First seen Apr 24, 2026 · Last updated May 09, 2026 · Updated 3 times
Summary
This study tested whether a combination of two targeted drugs (dabrafenib and trametinib) could keep melanoma from coming back after surgery in people with high-risk, BRAF-mutated skin cancer. About 870 patients took either the drug combo or placebos for 12 months. The main goal was to see if the treatment lengthened the time before the cancer returned or death occurred. Results showed the drug combo significantly reduced the risk of recurrence compared to placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Birmingham, Alabama, 35243, United States
-
Novartis Investigative Site
Tucson, Arizona, 85724, United States
-
Novartis Investigative Site
San Francisco, California, 94115, United States
-
Novartis Investigative Site
San Francisco, California, 94143, United States
-
Novartis Investigative Site
Aurora, Colorado, 80045, United States
-
Novartis Investigative Site
Lake Worth, Florida, 33461, United States
-
Novartis Investigative Site
Orlando, Florida, 32806, United States
-
Novartis Investigative Site
Tampa, Florida, 33612, United States
-
Novartis Investigative Site
Atlanta, Georgia, 30322, United States
-
Novartis Investigative Site
Atlanta, Georgia, 30341, United States
-
Novartis Investigative Site
Lutherville-Timonium, Maryland, 21093, United States
-
Novartis Investigative Site
Boston, Massachusetts, 02114, United States
-
Novartis Investigative Site
Boston, Massachusetts, 02115, United States
-
Novartis Investigative Site
Ann Arbor, Michigan, 48019, United States
-
Novartis Investigative Site
Winston-Salem, North Carolina, 27157, United States
-
Novartis Investigative Site
Columbus, Ohio, 43210, United States
-
Novartis Investigative Site
Portland, Oregon, 97123, United States
-
Novartis Investigative Site
Pittsburgh, Pennsylvania, 15232, United States
-
Novartis Investigative Site
Nashville, Tennessee, 37203, United States
-
Novartis Investigative Site
Dallas, Texas, 75390, United States
-
Novartis Investigative Site
Capital Federal, Buenos Aires, C1426ANZ, Argentina
-
Novartis Investigative Site
Buenos Aires, C1125ABD, Argentina
-
Novartis Investigative Site
Gateshead, New South Wales, 2290, Australia
-
Novartis Investigative Site
North Sydney, New South Wales, 2060, Australia
-
Novartis Investigative Site
Tweed Heads, New South Wales, 2485, Australia
-
Novartis Investigative Site
Westmead, New South Wales, 2145, Australia
-
Novartis Investigative Site
Greenslopes, Queensland, 4120, Australia
-
Novartis Investigative Site
Woolloongabba, Queensland, 4102, Australia
-
Novartis Investigative Site
Adelaide, South Australia, 5000, Australia
-
Novartis Investigative Site
Box Hill, Victoria, 3128, Australia
-
Novartis Investigative Site
Heidelberg, Victoria, 3084, Australia
-
Novartis Investigative Site
Melbourne, Victoria, 3004, Australia
-
Novartis Investigative Site
Nedlands, Western Australia, 6009, Australia
-
Novartis Investigative Site
Graz, 8036, Austria
-
Novartis Investigative Site
Linz, A-4010, Austria
-
Novartis Investigative Site
Salzburg, A-5020, Austria
-
Novartis Investigative Site
Vienna, 1090, Austria
-
Novartis Investigative Site
Wels, A-4600, Austria
-
Novartis Investigative Site
Brussels, 1200, Belgium
-
Novartis Investigative Site
Leuven, 3000, Belgium
-
Novartis Investigative Site
Liège, 4000, Belgium
-
Novartis Investigative Site
Wilrijk, 2610, Belgium
-
Novartis Investigative Site
Curitiba, Paraná, 81520-060, Brazil
-
Novartis Investigative Site
Ijuí, Rio Grande do Sul, 98700, Brazil
-
Novartis Investigative Site
Edmonton, Alberta, T6G 1Z2, Canada
-
Novartis Investigative Site
Hamilton, Ontario, L8V 5C2, Canada
-
Novartis Investigative Site
Oshawa, Ontario, L1G 2B9, Canada
-
Novartis Investigative Site
Ottawa, Ontario, K1H 8L6, Canada
-
Novartis Investigative Site
Toronto, Ontario, M5G 2M9, Canada
-
Novartis Investigative Site
Québec, Quebec, G1J 1Z4, Canada
-
Novartis Investigative Site
Brno, 656 53, Czechia
-
Novartis Investigative Site
Prague, 100 34, Czechia
-
Novartis Investigative Site
Prague, 128 08, Czechia
-
Novartis Investigative Site
Zlín, 76275, Czechia
-
Novartis Investigative Site
Arhus C, 8000, Denmark
-
Novartis Investigative Site
Herlev, 2730, Denmark
-
Novartis Investigative Site
Odense, 5000 C, Denmark
-
Novartis Investigative Site
Bordeaux, 33075, France
-
Novartis Investigative Site
Boulogne-Billancourt, 92100, France
-
Novartis Investigative Site
Brest, 29609, France
-
Novartis Investigative Site
Dijon, 21079, France
-
Novartis Investigative Site
Grenoble, 38043, France
-
Novartis Investigative Site
Lille, 59037, France
-
Novartis Investigative Site
Marseille, 13385, France
-
Novartis Investigative Site
Montpellier, 34295, France
-
Novartis Investigative Site
Nice, 06202, France
-
Novartis Investigative Site
Paris, 75014, France
-
Novartis Investigative Site
Paris, 75475, France
-
Novartis Investigative Site
Pierre-Bénite, 69495, France
-
Novartis Investigative Site
Reims, 51092, France
-
Novartis Investigative Site
Rennes, 35042, France
-
Novartis Investigative Site
Toulouse, 31059, France
-
Novartis Investigative Site
Tours, 37044, France
-
Novartis Investigative Site
Villejuif, 94805, France
-
Novartis Investigative Site
Freiburg im Breisgau, Baden-Wurttemberg, 79104, Germany
-
Novartis Investigative Site
Heilbronn, Baden-Wurttemberg, 74078, Germany
-
Novartis Investigative Site
Mannheim, Baden-Wurttemberg, 68167, Germany
-
Novartis Investigative Site
Tübingen, Baden-Wurttemberg, 72076, Germany
-
Novartis Investigative Site
Ulm, Baden-Wurttemberg, 89081, Germany
-
Novartis Investigative Site
Munich, Bavaria, 80337, Germany
-
Novartis Investigative Site
Nuremberg, Bavaria, 90419, Germany
-
Novartis Investigative Site
Regensburg, Bavaria, 93053, Germany
-
Novartis Investigative Site
Würzburg, Bavaria, 97080, Germany
-
Novartis Investigative Site
Darmstadt, Hesse, 64297, Germany
-
Novartis Investigative Site
Marburg, Hesse, 35033, Germany
-
Novartis Investigative Site
Wiesbaden, Hesse, 65199, Germany
-
Novartis Investigative Site
Hanover, Lower Saxony, 30625, Germany
-
Novartis Investigative Site
Schwerin, Mecklenburg-Vorpommern, 19049, Germany
-
Novartis Investigative Site
Bochum, North Rhine-Westphalia, 44791, Germany
-
Novartis Investigative Site
Cologne, North Rhine-Westphalia, 50937, Germany
-
Novartis Investigative Site
Essen, North Rhine-Westphalia, 45147, Germany
-
Novartis Investigative Site
Mainz, Rhineland-Palatinate, 55131, Germany
-
Novartis Investigative Site
Magdeburg, Saxony-Anhalt, 39120, Germany
-
Novartis Investigative Site
Kiel, Schleswig-Holstein, 24105, Germany
-
Novartis Investigative Site
Lübeck, Schleswig-Holstein, 23538, Germany
-
Novartis Investigative Site
Erfurt, Thuringia, 99089, Germany
-
Novartis Investigative Site
Gera, Thuringia, 07548, Germany
-
Novartis Investigative Site
Berlin, 10249, Germany
-
Novartis Investigative Site
Athens, 11527, Greece
-
Novartis Investigative Site
Thessaloniki, 54622, Greece
-
Novartis Investigative Site
Thessaloniki, 56429, Greece
-
Novartis Investigative Site
Ramat Gan, 52621, Israel
-
Novartis Investigative Site
Rome, Lazio, 00167, Italy
-
Novartis Investigative Site
Genoa, Liguria, 16132, Italy
-
Novartis Investigative Site
Bergamo, Lombardy, 24127, Italy
-
Novartis Investigative Site
Milan, Lombardy, 20133, Italy
-
Novartis Investigative Site
Milan, Lombardy, 20141, Italy
-
Novartis Investigative Site
Candiolo, Piedmont, 10060, Italy
-
Novartis Investigative Site
Pisa, Tuscany, 56126, Italy
-
Novartis Investigative Site
Padova, Veneto, 35128, Italy
-
Novartis Investigative Site
Shizuoka, 411-8777, Japan
-
Novartis Investigative Site
Tokyo, 104-0045, Japan
-
Novartis Investigative Site
Amsterdam, 1066 CX, Netherlands
-
Novartis Investigative Site
Amsterdam, 1081 HV, Netherlands
-
Novartis Investigative Site
Groningen, 9713 GZ, Netherlands
-
Novartis Investigative Site
Leeuwarden, 8934 AD, Netherlands
-
Novartis Investigative Site
Maastricht, 6229 HX, Netherlands
-
Novartis Investigative Site
Nijmegen, 6525 GA, Netherlands
-
Novartis Investigative Site
Rotterdam, 3015 GD, Netherlands
-
Novartis Investigative Site
Auckland, 0622, New Zealand
-
Novartis Investigative Site
Ålesund, 6026, Norway
-
Novartis Investigative Site
Oslo, 0310, Norway
-
Novartis Investigative Site
Gdansk, 80-215, Poland
-
Novartis Investigative Site
Konin, 62-500, Poland
-
Novartis Investigative Site
Poznan, 60-693, Poland
-
Novartis Investigative Site
Warsaw, 02-781, Poland
-
Novartis Investigative Site
Chelyabinsk, 454087, Russia
-
Novartis Investigative Site
Moscow, 115478, Russia
-
Novartis Investigative Site
Moscow, 143423, Russia
-
Novartis Investigative Site
Ryazan, 390011, Russia
-
Novartis Investigative Site
Saint Petersburg, 191014, Russia
-
Novartis Investigative Site
Saint Petersburg, 197758, Russia
-
Novartis Investigative Site
Saint Petersburg, 198255, Russia
-
Novartis Investigative Site
Volgograd, 400138, Russia
-
Novartis Investigative Site
Badalona, 08916, Spain
-
Novartis Investigative Site
Barcelona, 08035, Spain
-
Novartis Investigative Site
Barcelona, 08036, Spain
-
Novartis Investigative Site
Donostia / San Sebastian, 20014, Spain
-
Novartis Investigative Site
Las Palmas de Gran Canaria, 35016, Spain
-
Novartis Investigative Site
Madrid, 28034, Spain
-
Novartis Investigative Site
Madrid, 28041, Spain
-
Novartis Investigative Site
Madrid, 28046, Spain
-
Novartis Investigative Site
Palma de Mallorca, 07198, Spain
-
Novartis Investigative Site
Pamplona, 31008, Spain
-
Novartis Investigative Site
Santander, 39008, Spain
-
Novartis Investigative Site
Valencia, 46014, Spain
-
Novartis Investigative Site
Gothenburg, SE-413 45, Sweden
-
Novartis Investigative Site
Lund, SE-221 85, Sweden
-
Novartis Investigative Site
Stockholm, SE-171 76, Sweden
-
Novartis Investigative Site
Uppsala, SE-751 85, Sweden
-
Novartis Investigative Site
Basel, 4031, Switzerland
-
Novartis Investigative Site
Chur, 7000, Switzerland
-
Novartis Investigative Site
Zurich, 8091, Switzerland
-
Novartis Investigative Site
Taipei, 10002, Taiwan
-
Novartis Investigative Site
Taoyuan, 33305, Taiwan
-
Novartis Investigative Site
Northwood, Middlesex, HA6 2RN, United Kingdom
-
Novartis Investigative Site
Exeter, EX2 5DW, United Kingdom
-
Novartis Investigative Site
Glasgow, G12 0YN, United Kingdom
-
Novartis Investigative Site
Guildford, GU2 7XX, United Kingdom
-
Novartis Investigative Site
Leeds, LS9 7TF, United Kingdom
-
Novartis Investigative Site
London, NW3 2QG, United Kingdom
-
Novartis Investigative Site
London, SW3 6JJ, United Kingdom
-
Novartis Investigative Site
London, W1G 6AD, United Kingdom
-
Novartis Investigative Site
Manchester, M20 4BX, United Kingdom
-
Novartis Investigative Site
Newcastle upon Tyne, NE7 7DN, United Kingdom
-
Novartis Investigative Site
Norwich, NR4 7UY, United Kingdom
-
Novartis Investigative Site
Preston, PR2 9HT, United Kingdom
-
Novartis Investigative Site
Southampton, SO16 6YD, United Kingdom
Conditions
Explore the condition pages connected to this study.